TITLE:
A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
vildagliptin

SUMMARY:

      The purpose of this study is to assess the safety and effectiveness of three doses of
      vildagliptin, an unapproved drug, compared to placebo in lowering overall blood glucose
      levels in people with type 2 diabetes who have not been previously treated with drug therapy
      to lower their blood sugar.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  Body mass index (BMI) in the range 22-45

          -  Blood glucose criteria must be met

          -  Not currently on drug therapy for type 2 diabetes

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Evidence of serious diabetic complications

          -  Evidence of serious cardiovascular conditions

          -  Laboratory value abnormalities as defined by the protocol

          -  Other protocol-defined exclusion criteria may apply
      
